Coya Therapeutics, Inc. share price logo

Coya Therapeutics, Inc.

NASDAQ: COYA

$4.22

-0.03

(-0.59%)

as on

Coya Therapeutics, Inc. Stock Performance

as on October 20, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.21
    $4.43
    downward going graph

    0.24%

    Downside

    4.98%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.71
    $7.55
    downward going graph

    12.08%

    Downside

    78.91%

    Upside

    downward going graph

Coya Therapeutics, Inc. share price movements today

Previous Close
$4.25
Open
$4.43
Volume
321.7K
Market Cap
$99.7M
Day's Low - High
$4.21 - $4.43
52 Week Low - High
$3.71 - $7.55

Coya Therapeutics, Inc. Historical Returns

1 Month Return
-13.09 %
3 Month Return
-6.39 %
1 Year Return
-33.18 %
3 Year Return
-17.15 %
5 Year Return
0 %

Coya Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Coya Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$99.7M

EPS (TTM)

-1.07

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.97

Industry PE ratio

-3.10

PEG Ratio

-0.37

EBITDA

-22.1M

Revenue (TTM)

8.0M

Profit Margin

99.91%

Return On Equity TTM

-53.32%

Coya Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Coya Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Coya Therapeutics, Inc. image
Coya Therapeutics, Inc.
Buy$99.7MNA-3.9799.91%0.00%
Moderna image
Moderna
Neutral$87.0B-34.65%-29.64-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$126.7B169.53%28.8586.04%0.00%
Regeneron image
Regeneron
Buy$81.4B43.22%19.0184.86%0.47%

Stock Returns calculator for Coya Therapeutics, Inc. Stock including INR - Dollar returns

The Coya Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Coya Therapeutics, Inc. investment value today

Current value as on today

₹71,668

Returns

-₹28,332

(-28.33%)

Returns from Coya Therapeutics, Inc. Stock

-₹33,648 (-33.65%)

Dollar Impact

₹5,316 (+5.32%)

Analyst Recommendation on Coya Therapeutics, Inc. Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Coya Therapeutics, Inc.. Average target price of $15.21

Coya Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Coya Therapeutics, Inc..

What analysts predicted

72.26%UPSIDE

Target Price

$15.21

Current Price

$4.22

Analyzed by

2 Analysts

High

$18

Target

$15.21

Low

$16

Coya Therapeutics, Inc. target price $15.21, a slight upside of 72.26% compared to current price of $4.22. According to 2 analysts rating.

Indian Investors' Interest in Coya Therapeutics, Inc. Stock

Search interest for Coya Therapeutics, Inc. Stock has increased by 126% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:126% versus previous 30 day period

Coya Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
3
-
0
0
0
3
3
0
0
Gross Profit
-3
-1
-2
-1
-4
0
3
3
0
0
Operating Income
-5
-3
-4
-4
-7
-6
-1
-6
-7
-7
EBITDA
-5
-2
-4
-3
-7
-6
-2
-5
-7
-6
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-2
-4
-3
-7
-6
-2
-5
-7
-6
Income Tax Expense
-
-
-
0
-
-
-
0
-
-
Net Income
-5
-2
-4
-2
-7
-6
-2
-5
-7
-6
Net Profit Margin
-2374.15%
-33.31%
0.00%
-99154.10%
-1921.87%
95.82%
99.81%
100.00%
100.00%
100.00%

Coya Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
6
3
7
Gross Profit
-
-
-4
0
-8
7
Operating Income
-1
-4
-9
-7
-17
-20
EBITDA
-
-4
-9
-7
-17
-21
Interest Expense
0
-
-
-
-
-
Depreciation
0
0
0
0
0
0
Income Before Tax
-1
-4
-12
-7
-15
-21
Income Tax Expense
-
-
-
0
0
0
Net Income
-1
-4
-12
-7
-14
-21
Net Profit Margin
0.00%
0.00%
0.00%
8.34%
-233.86%
99.66%

Coya Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-5
-2
-4
-2
-7
-6
-2
-5
-7
-13,838
Operating Cash Flow
2
-4
-5
-2
-2
-5
-1
-1
-6
-13,674
Investing Cash Flow
0
-
-
-
-
-
0
0
0
-885
Financing Cash Flow
1
5
0
9
0
-
0
20
10
21,760
Change in Cash
3
0
-5
7
-2
-5
-1
18
3
7,200

Coya Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-4
-12
-7
-14
-21
Operating Cash Flow
0
-3
-7
-11
-10
-10
Investing Cash Flow
-
0
0
0
0
-1
Financing Cash Flow
9
0
9
38
16
20
Change in Cash
8
-4
1
26
5
8

Global Institutional Holdings in Coya Therapeutics, Inc.

Check out the Institutions with significant holdings in Coya Therapeutics, Inc..

Funds
Holdings
Vanguard
3.55%
VANGUARD INDEX FUNDS
3.50%
Fidelity Concord Street Trust
0.66%
DFA
0.45%
iShares
0.27%
See all

Coya Therapeutics, Inc. News & Key Events

  • img

    Today's Timeline - 14 October

    Wed, 06:30 PM

    -

    Coya Therapeutics launches open-label extension of ALSTARS Trial for COYA 302 in ALS, prioritizing key milestones.

Insights on Coya Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 771.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 164.7% return, outperforming this stock by 181.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, COYA stock has moved down by -11.6%

About Coya Therapeutics, Inc.

Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipeline leverages diverse approaches, including biologics designed to enhance Treg activity, Treg-derived exosomes, and personalized autologous Treg cell therapies. Among its lead candidates is COYA 101, an autologous regulatory T-cell product that has successfully completed Phase 2a clinical trials for treating Amyotrophic Lateral Sclerosis (ALS). Moving towards Investigational New Drug (IND) applications are two key candidates: COYA 301 and COYA 302. COYA 301 is a Treg-enhancing biologic aimed at treating Frontotemporal Dementia. Meanwhile, COYA 302 is a dual-action biologic combination, suitable for subcutaneous or intravenous delivery, engineered to not only boost Treg function but also to diminish harmful T effector cell activity and activated macrophages in neurodegenerative and autoimmune disorders. Additionally, Coya has earlier-stage programs, including COYA 201, an allogeneic (off-the-shelf) Treg exosome candidate in preclinical development for a range of neurodegenerative, autoimmune, and metabolic conditions. Its pipeline also features COYA 206, an antigen-directed Treg-derived exosome product, currently in the discovery phase. Established in 2020, Coya Therapeutics maintains its headquarters in Houston, Texas.
OrganisationCoya Therapeutics, Inc.
Headquarters5850 San Felipe Street, Houston, TX, 77057, US
IndustryBiotechnology
CEOArun Swaminathan

Key Management of Coya Therapeutics, Inc.

Name

Title

Ms. Karen King M.S.

Senior VP of Program Management & Clinical Operations

Dr. Arun Swaminathan Ph.D.

CEO & Director

Dr. Fred Grossman D.O., FAPA

President & Chief Medical Officer

Mr. David S. Snyder M.B.A.

CFO & COO

Mr. Aaron Thome Ph.D.

Head of Neuroinflammation Platform

Dr. Michelle Frazier Ph.D.

Senior Vice President of Regulatory

FAQs

What is Coya Therapeutics, Inc. share price today?

Coya Therapeutics, Inc. share price today is $4.22 as on at the close of the market. Coya Therapeutics, Inc. share today touched a day high of $4.43 and a low of $4.21.

What is the 52 week high and 52 week low for Coya Therapeutics, Inc. share?

Coya Therapeutics, Inc. share touched a 52 week high of $7.55 on and a 52 week low of $3.71 on . Coya Therapeutics, Inc. stock price today i.e. is closed at $4.22,which is 44.11% down from its 52 week high and 13.74% up from its 52 week low.

What is Coya Therapeutics, Inc.'s market capitalisation today?

Coya Therapeutics, Inc. market capitalisation is $0.00T as on .

How to invest in Coya Therapeutics, Inc. Stock (COYA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Coya Therapeutics, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Coya Therapeutics, Inc. Stock (COYA) from India?

Indian investors can start investing in Coya Therapeutics, Inc. (COYA) shares with as little as ₹94.91500091552734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.15 in Coya Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Coya Therapeutics, Inc. share’s latest price of $4.22 as on October 20, 2026 at 1:29 am IST, you will get 2.3697 shares of Coya Therapeutics, Inc.. Learn more about fractional shares .